Anderson J L, Fowles R E, Bieber C P, Stinson E B
Lancet. 1978 Dec 2;2(8101):1174-7. doi: 10.1016/s0140-6736(78)92156-6.
A review of lymphomas developing in recipients of cardiac allografts has yielded significant risk factors. Frequency varied strikingly according to original cardiac disease: lymphoma developed in 6 of 37 patients with prior idiopathic cardiomyopathy (I.C.M.) but in one of 54 patients with prior coronary-artery disease (C.A.D.). All patients who developed lymphomas were aged under 40. Combination of both risk factors (I.C.M. and age less than 40) produces a sub-group with a highly significantly increased risk of lymphoma. I.C.M., but not C.A.D., is characterised by a defect in mitogen-induced mononuclear-cell suppressor activity. It is postulated that defective regulation in the immune systems of younger patients under chronic alloantigen stimulation may allow lymphoid proliferation to proceed to lymphoreticular malignancy. Immunosuppressive agents such as azathioprine may exert a co-oncogenic effect.
一项关于心脏同种异体移植受者发生淋巴瘤的综述得出了一些重要的危险因素。淋巴瘤的发病率根据原发心脏疾病的不同而有显著差异:37例既往有特发性心肌病(I.C.M.)的患者中有6例发生淋巴瘤,而54例既往有冠状动脉疾病(C.A.D.)的患者中仅有1例发生淋巴瘤。所有发生淋巴瘤的患者年龄均在40岁以下。两种危险因素(I.C.M.和年龄小于40岁)同时存在会产生一个淋巴瘤风险显著升高的亚组。I.C.M.(而非C.A.D.)的特征是有丝分裂原诱导的单核细胞抑制活性存在缺陷。据推测,在慢性同种异体抗原刺激下,年轻患者免疫系统的调节缺陷可能会使淋巴样增殖发展为淋巴网状恶性肿瘤。硫唑嘌呤等免疫抑制剂可能会发挥协同致癌作用。